SEI Investments
RAPP

SEI Investments’s Rapport Therapeutics RAPP Stock Holding History

SEI Investments’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Sell
16,294
-14,525
-47% -$534K ﹤0.01% 2505
2026
Q1 		$964K Buy
30,819
+12,551
+69% +$353K ﹤0.01% 2371
2025
Q4 		$554K Buy
18,268
+10,115
+124% +$280K ﹤0.01% 2472
2025
Q3 		$242K Buy
+8,153
New +$145K ﹤0.01% 2547

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

SEI Investments's RAPP Position: Q2 2026 in Review

SEI Investments reduced its Rapport Therapeutics (RAPP) stake by 47% in Q2 2026, selling an estimated $534K and leaving 16,294 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

SEI Investments first reported a position in RAPP in Q3 2025 and has held it in 4 quarters since. The position peaked at $964K in Q1 2026. 160 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • SEI Investments held 16,294 shares of Rapport Therapeutics worth $679K as of Q2 2026.
  • SEI Investments sold 14,525 Rapport Therapeutics shares in Q2 2026, an estimated $534K.
  • Rapport Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2505 holding.
  • SEI Investments first reported a position in Rapport Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • SEI Investments's Rapport Therapeutics position peaked at $964K in Q1 2026.
  • 160 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.